Abbreviations: BMC, bacterial microcompartment; enhanced biological phosphorus removal , EBPR; PPK1, polyphosphate kinase; PPX, exopolyphosphatase.
Introduction 1
Polyphosphate is a molecule thought to be present in all organisms [1] playing a role in 2 cellular metabolic processes, stress response processes, virus replication and cell structure 3
[2]. Bacterial polyphosphate accumulation underlies the enhanced biological phosphorus 4 removal (EBPR) process, which uses microorganisms to remove inorganic phosphate (Pi) 5 from wastewater [3] . Phosphate recovery processes are required to reduce eutrophication, 6 the overgrowth of cyanobacteria and plants in water polluted by excess phosphorus from 7 human activity [4] , and because of the unsustainability of current phosphorus resources 8 beyond the next century [5] . In EBPR, cycling of wastewater sludge through aerobic and 9 anaerobic phases of incubation lasting several hours, when continued over a period of 10 weeks selects a bacterial consortium that has a net effect of removing phosphorus from 11 wastewater over the cycle by accumulating it in the sludge. Polyphosphate-accumulating 12 bacteria are key consortium components [6, 7] . Phosphate release from the consortium 13 occurs in the anaerobic phase in parallel with consumption of volatile fatty acids, 14 polyhydroxyalkanoate polymer formation and glycogen utilisation. In the aerobic phase 15 stored polyhydroxyalkanoate is catabolised, glycogen replenished and phosphate taken up 16 to form polyphosphate granules [7] . EBPR is a complex dynamic process -an uncultured 17 bacterium Candidatus Accumulibacter phosphatis performs a key role in EBPR 18 polyphosphate accumulation [8] , and an established EBPR reactor may fail for unknown 19 reasons [3, 9] . 20
21
Genetic manipulation of aspects of phosphate binding, uptake and storage by a single 22 model organism such as E. coli has been suggested as an alternative or additive approach 23 to biological phosphorus removal [10] [11] [12] [13] . One issue with over-expression of a 1 polyphosphate forming enzyme in E. coli has been that most of the consequent increase of 2 polyphosphate is temporary, probably because of the existence of competing catabolic 3 enzymes [14, 15] and phosphate release from the cells then occurs as the polyphosphate is 4 broken down. 5
6
In E. coli polyphosphate kinase PPK1 (E.C. 2.7.4.1) is the enzyme responsible for 7 assembling inorganic polyphosphate polymers in the bacterial cytoplasm by catalysing the 8 reaction nATP ⥂ (polyphosphate)n + nADP [16, 17] . Although this is a reversible reaction, 9 in E.coli this enzyme generally favours synthesis of polyphosphate over breakdown (Vmax 10 ratio of 4.1) [17] (Fig.1A) . However, the balance between net accumulation and breakdown 11 changes dynamically during culture growth and also in response to external stimuli, in part 12 due to the action of degradative exopolyphosphatases. In this respect E. coli contains two 13 such polyphosphatases that release orthophosphate from the termini of long chain 14 polyphosphate: (polyphosphate)n → (polyphosphate)n-l + Pi. The two polyphosphatases 15 are called PPX (E.C. 3.6.1.11, sometimes referred to as PPX1) [18, 19] , which is encoded 16 in the same operon as PPK1, and its homologue guanosine pentaphosphate 17 phosphohydrolase (GPPA or PPX2) [17, 20] . GPPA (E.C. 3.6.1.40) also hydrolyses 18 guanosine pentaphosphate (pppGpp) to guanosine tetraphosphate (ppGpp) with phosphate 19 release as part of the control of the stringent response. Both PPX and GPPA are 20 competitively inhibited by pppGpp [21] . Consequently, amino acid starvation in E. coli 21 leads to the accumulation of large amounts of polyphosphate due to the high levels of 22 pppGpp produced as part of the stringent response [21] . In E. coli ppk1 and ppx are adjacent 23 genes forming an operon and knockout of ppx alone has been engineered by combined 1 knockout of ppk1 and ppx with heterologous plasmid expression of ppk1 [15, 22, 23] . 2 Elevation of polyphosphate levels in these cells rapidly declines a few hours after ppk1 3 plasmid induction whether ppx is active or knocked out [15] , showing that PPX is not the 4 sole cause of instability in polyphosphate levels in E. coli. We hypothesized that an 5 alternative approach to prevent the access of all other cytoplasmic enzymes, (not just PPX) 6 to polyphosphate formed from recombinant PPK1 would stabilise cellular polyphosphate 7 levels and create a phosphate-retaining phenotype. The mechanism used to achieve this is 8
targeting of PPK1 to a recombinant bacterial microcompartment. 9
10
Bacterial microcompartments (BMCs) are proteinaceous vesicles found in certain bacteria 11 that house specific metabolic pathways encased within a closed polyhedral shell of 100-12 150 nm diameter. The shells are made of thin protein sheets [24] containing pores less than 13 1 nm in diameter [25] which can be positively or negatively charged. There are two broad 14 groups of BMCs, those associated with the anabolic process of RuBisCO-mediated carbon 15 fixation (carboxysomes) and those associated with catabolic fermentative processes such 16 as 1,2-propanediol utilisation (metabolosomes) [26, 27] . Although BMCs were first seen 17 over fifty years ago in photosynthetic cyanobacteria [28] , their presence in the cytoplasm 18 of heterotrophic bacteria was only confirmed in 1998 [29] after they were detected in thin 19 sections of Salmonella enterica grown on 1,2-propanediol. In fact, around twenty per cent 20 of bacterial genome sequences contain BMC structural genes [26] 
Targeting of PPK1 21
The strategy used is summarised in Supplementary Data Fig.S1 . The ppk1 gene coding for 22 polyphosphate kinase (PPK1) was PCR-amplified with a proofreading DNA polymerase 23 (Bioline High Velocity Polymerase, Bioline UK, London), using genomic DNA from E. 1 coli JM109 as template, using the forward primer ppk1-F and a reverse primer ppk1-R 2 (Table S1 ). The PCR product was digested with Sac I and Hind III (Fermentas) followed 3 by ligation to pET23b-GFP-pduP18 digested with Sac I and Hind III. The gene encoding 4 the GFP was thus replaced by ppk with retention of the pdu localization sequence. The 5 ligation product was transformed into E. coli Top 10 electrocompetent cells (Invitrogen) 6 by electroporation. The new vector, named pML001 (pET23bpduP18-ppk1), was extracted 7 and the ppk1 insert was sequenced (GATC-Biotech) to confirm no mutation had occurred. 8
Two constructs, pML001 and pLysSpduABJKNU (pSF37), expressing an empty pdu BMC 9
[37]), were co-transformed into E. coli BL21 (DE3) by heat shock. incubator at room temperature and on ice for 5 min. After initial removal of cell debris by 23 centrifugation at 12,000 g for 5 min at 4°C repeated twice, the BMC fraction was 1 precipitated by spinning at 20,000 g for 20 min at 4°C. The pellet was washed once with a 2 mixture of 4 ml of buffer A and 6 ml of BPER-II and resuspended in 0.5 ml of buffer B 3 (50mMTris-HCl pH 8.0, 50 mM KCl, 5 mM MgCl2, 1% 1,2-PD) containing Complete 4
Protease Inhibitor Cocktail (Roche) at the manufacturer's recommended working dilution. 5
Remaining cell debris was removed by centrifugation for 1 min at 12,000 g 4°C repeated 6 three times. A -PAGE using a 7 15% polyacrylamide gel under denaturing conditions in a MiniProtean apparatus (Bio-Rad) 8
and stained with Coomassie Brilliant Blue R250 (Fig.1B) . Peptide fingerprinting carried 9 out as previously described [47] . In microcompartment extraction for ATP regeneration 10 assays (Fig. 1C,D) and whole cell polyphosphate assays (Fig 2) CelLytic B (Sigma-11 Aldrich) was initially substituted for BPER-II because of published efficacy of this reagent 12 for polyphosphate extraction [48] . In later microcompartment extractions (Fig. 3) 
ATP regeneration assay 19
A combination of two previously described PPK1 assay methods [48, 50] using luciferase 20 to detect ATP produced from polyphosphate by PPK1 was used as a biochemical screen 21
for the presence of PPK1 and polyphosphate in microcompartment fractions. Briefly, to 22 containing: ultrapure ADP (ATP-free, Cell Technology Inc, Ca), 30 mM MgCl2, 1% (w/v) 1 Polyphosphate (Sigma), 50 mM Tris-HCl (pH 7.8). The reaction mixture was diluted 1:100 2 in 100 mM Tris-HCl (pH 8.0)-4 mM EDTA, of which 0.1 mL was added to 0.1 mL of 3 luciferase reaction mixture from ATP Bioluminescence Assay Kit CLS II (Roche). 4
Luminescence was measured by using a luminometer (Luminoskan, Thermo Labsystems). 5
A standard curve for ATP by dilution in 100 mM Tris-HCl (pH 8.0) containing 4 mM 6 EDTA was used. To assay relative polyphosphate content, the same reaction omitting 7 added polyphosphate was performed ( Figure 1C ). 8 9
Co-expression of targeted and untargeted PPK1 and PPX 10
The pCOLADuet-1 coexpression vector (Novagen) system encoding two multiple cloning 11 sites (MCS) each preceded by a T7 promoter, lac operator, and ribosome binding site was 12 used to express targeted and untargeted E. coli PPK1 and PPX (ppx amplified from E. coli 13 JM109) in combination (pYY005, pYY007, pYY008) and alone (pYY002, pYY010) (see 14 Table 1) . 15
Polyphosphate concentration presented in Fig. 3 was determined following lysis of pelleted 16 cells from 10 ml of cultures described above. A metachromatic assay was employed using 17 the 530/630nm absorbance ratio of 10 μL of lysate added to 1 mL of toluidine dye solution 18 (6 mg/L toluidine blue in 40 mM acetic acid) as described [51] . In later experiments ( Fig.  19 4) polyphosphate was determined by a higher-yielding method using 4'-6-diamidino-2-20 phenylindole (DAPI) as described [52] on whole cells or microcompartment cell fractions 21 obtained with BPER-II extraction. Briefly, cells were harvested by centrifuging at 5000g 22 for 10 min at 4° C. After washing in 50mM HEPES buffer (pH7.5) the cell pellet or 23 microcompartment fraction was frozen at -20° C followed by defrosting at room 1 temperature. Cell pellets/microcompartment fractions were resuspended in HEPES buffer 2 at an appropriate dilution to ensure that the cellular polyP concentration was in the linear 3 range of the DAPI assay (0-4 100 µL of polyP containing samples and 200 μL of DAPI assay buffer containing 150 mM 5
KCl, 20 mM HEPES-KOH (pH 7.0) and 10 μM DAPI solution. After a 10 min incubation 6 at room temperature DAPI fluorescence was measured with a platereader equipped with 7 excitation and emission filters of 420 nm and 550 nm respectively. 8 9 A polyphosphate standard curve was prepared using sodium phosphate glass Type 45 10 (S4379 Aldrich) and sodium hexametaphosphate (SX0583). Protein concentration of cell 11 extracts was measured using a 10μL sample, with Coomassie Plus Protein Assay Reagent 12 (Pierce) with bovine serum albumin as the standard resuspended in the same buffer as the 13 sample. 14 15 Phosphate uptake was determined as follows ( Fig. 2A) . Bacteria was grown to OD600 0.4-16 0.6 in Luria broth and then induced by 0.5 mM of IPTG for 1 hr before transfer to pH 5.5 17 MOPS medium [44] containing 0.01 mM iron and 0.5 mM potassium phosphate, at an 18 OD600 of 0.2. Incubation was continued at 37°C with intermittent sampling of 0.2 mL up 19 to 48 hrs. Samples were centrifuged and supernatant used for phosphate assay, and the 20 pellet used for polyphosphate and protein assays. Phosphate was assayed using a 21 molybdovanadate colorimetric method [53] . 0.2 mL of molybdovanadate solution 22
(Reagecon, cat no: 1056700) was added to 5 mL of culture supernatant, mixed and 23 incubated at room temperature for 5 min. Optical density of 1 mL at 430 nm was measured 1 against a blank of 4% molybdovanadate in distilled water and a calibration curve of 2 potassium phosphate in MOPS. 3 4
Light Microscopy 5
Polyphosphate granules were visualised in fixed films (Fig. 4) by Neisser's stain using 6
Chrysoidin counterstain [54] . 7 8
Electron Microscopy 9
E. coli BL21(DE3) cells containing targeted/untargeted PPK1 and pLySsPduABJKNU (for 10 expressing empty microcompartments) were grown in 50 mL of LB broth containing 100 11 mg/litre ampicillin and 32 mg/L chloramphenicol with shaking at 37 °C. Upon reaching an 12 OD600 of 0.5, protein production was induced with 0.5 mM isopropyl-D-thiogalactoside, 13 and the cultures were incubated by shaking overnight at 18 °C. Harvested cells were 14 resuspended in 2 mL of fixative consisting of 2.5% glutaraldehyde in 100 mM sodium 15 cacodylate (CAB) buffer (pH 7.2). The cells were pelleted and washed twice with CAB to 16 remove traces of the fixing solution. Cells were then stained for 1 hr in 1% osmium 17 tetroxide (w/v) and washed with CAB before dehydration. Dehydration was carried out by 18 placing the samples into an ethanol gradient: 50%, 70%, 90% once for 10 minutes, and 19 100% dried ethanol three times for 15 minutes. Samples were rinsed twice for 15 minutes 20 in propylene oxide and then incubated in 50/50 propylene oxide/Agar LV resin for 30 21 minutes. Samples were incubated 2 x 2 hr in fresh Agar LV resin before embedding in 22
Beem capsules by centrifugation at 11,000 rpm for 5 minutes followed by incubation at 60 23 °C overnight to polymerize. Specimens were thin sectioned with a diamond knife on an 1 RMC MT-6000-XL ultramicrotome, collected on 400 mesh copper grids, and post-stained 2 with 4.5% uranyl acetate for 45 min at RT and lead citrate for 7 min at RT. Sections were 3 then observed and photographed with a JEOL-1230 transmission electron microscope at 4 an accelerating voltage of 80 kV. 5 6 Electron microscopy for parallel electron energy loss spectroscopy (PEELS) and 7
element mapping by electron spectroscopic imaging (ESI) 8
Unstained cells were fixed in 3% (v/v) glutaraldehyde -10 mM Hepes, pH 7.3 (Sigma), 9 dehydrated in an acetone-series and embedded in epoxy resin (Spurr, hard mixture; [55]), 10 as described [56] . For elemental analysis 30 -40 nm ultrathin sections (otherwise 90 nm 11 for general ultrastructure) were sectioned with a Reichelt-Jung ultramicrotome (Leica, 12
Vienna, Austria), equipped with a diamond knife and were picked up with 300 mesh Cu-13 grids. Electron micrographs were recorded in the elastic brightfield mode (slit width: 10 14 eV) with an EF-TEM (operated in general at 120 kV acceleration voltage), equipped with 15 an in-column Omega-type energy filter (LIBRA120 plus, Zeiss, Oberkochen Germany), in 16 a magnification range from x 4000 to x 32000 with a bottom-mount cooled 2048 x 2048 17 CCD camera (sharp:eye; Tröndle, Moorenweis, Germany). 18
19

Parallel electron energy loss spectroscopy (PEELS) 20
Spot-PEELS were recorded within electron dense cytoplasmic inclusion bodies. Spot-size 21 was set to 16 nm and the objective aperture was 60 μm (spectrum magnification: x100; 22 energy range: 67 -290 eV; recording time: 10 s ; emission current: 1 μA) and the spectrum 23 energy resolution was about 1.6 eV at zero-loss (FWHM). Recorded PEELS data were 1 corrected for background, applying the 'potence' underground function of the EsiVision 2 Pro Software (EsiVision Pro, Vers. 3.2; SIS -Soft Imaging Systems, Munster, Germany) 3 and were 'medium'-filtered (settings: 1.5 eV width). 4 5
Element mapping by electron spectroscopic imaging (ESI) 6
Phosphorus mapping was performed as previously described [56] with unstained 35 nm 7 ultrathin sections. According to the '3-window method' energy-windows were set to a 8 dedicated energy loss for the P-L23 edge, as it was given by the corresponding first 9
intensity maximum from the spot-PEELS, i.e. 138 eV (W1: 125 eV; W2: 115 eV). The 10 energy selective slit was set to 6 eV width, and images were recorded with an illumination 11 aperture of 0.63 mrad, an emission current of 1 μA, a 60 μm objective aperture, and a 12 nominal magnification of x 6300. Background subtraction for calculating the phosphorus 13 element map was performed by the 'multiwindow exponential difference' method. 14 15
Results 16
BMC localisation of PPK1 17
The localisation of PPK1 to a recombinant BMC was achieved by engineering the fusion 18 of the P18 targeting peptide to the N-terminus of the enzyme. The recombinant BMC with 19 the associated P18-PPK1 was isolated after lysis of the cells using a protein extraction 20 reagent followed by differential salt precipitation and centrifugation. Analysis of the 21 purified BMC fraction by SDS-PAGE revealed the presence of P18-PPK1 together with 22 the BMC-associated shell proteins (Fig. 1B) . 23 1 A functional assay designed to maximise PPK1's ATP breakdown function was employed 2 to determine the activity of PPK1 when it was directed to the BMC. In comparison to BMC 3 extracts from cells producing only empty BMCs or empty BMCs and non-targeted PPK, 4 the purified BMC cell fractions from the cells co-producing BMCs and P18-PPK1 5 generated over twenty-fold more ATP per mg of protein from added polyphosphate 6 (Fig.1C) . There was little activity in the equivalent protein fraction that had been prepared 7 from cells producing only P18-PPK1 (i.e. P18-PPK1 produced in the absence of BMCs). 8
This showed that polyphosphate kinase activity had been transferred to the 9 microcompartments by enzyme targeting. 10
11
The same ATP regeneration assay was run again but this time in the absence of any added 12 exogenous polyphosphate (Fig.1D) . Any ATP generated in this assay would therefore 13 reflect the amount of endogenous polyphosphate within the fraction. The BMC fraction 14 from the cells that co-produced both the BMCs and P18-PPK1 generated more than twice 15 as much ATP as control BMC fractions from cells expressing empty BMCs or BMCs with 16 non-targeted PPK1 (Fig. 1D ). This result indicates that the BMC fraction from cells co-17 expressing targeted PPK1 had increased levels of polyphosphate, compatible with 18 localisation of PPK1 to the microcompartment and formation of polyphosphate in situ. 19 20 PPK1 targeting effect on polyphosphate content and phosphate uptake, 21
The effect of PPK1 overexpression on cellular polyphosphate was both qualitative and 22 quantitative, and targeted PPK1 with co-expressed BMCs gave a distinct phenotype. DAPI 23 negative staining of polyphosphate extracts, size-separated on a PAGE gel (Supplementary 1 Data Figure S2 ), showed that the polyphosphate detected in strains over-expressing either 2 p18ppk1 alone or p18ppk1 and pduABJKNU exceeded the length of the sodium phosphate 3 glass Type 45 polyphosphate control. This indicates that long chain polyphosphate is 4 present in these strains. No qualitative difference in chain length was detected between 5 these two clones but long chain polyphosphate in the E. coli strain over expressing p18ppk1 6 and recombinant BMCs persisted to a later phase of growth (Fig. S2) 
A simultaneous assay of the cellular polyphosphate and phosphate content of the culture 10 supernatant from the cultures used in the polyphosphate chain length assay was also 11 undertaken. Here, increased phosphate uptake from culture medium was observed in 12 comparison to the host E. coli control ( Fig. 2A) by both the p18ppk1-expressing strain and 13 the strain expressing both p18ppk1 and pduABJKNU. A maximal uptake of approximately 14 0.25 mM at 20 hours was observed for both constructs. However, the p18ppk-expressing 15 strain returned a third of this phosphate to the supernatant after 48 hours, while the strain 16 expressing both p18ppk1 and pduABJKNU returned less than 9% of phosphate taken by 48 17 hours. Correspondingly, the cell associated polyphosphate levels of the p18ppk1 clone 18 were maximal at 20 hours and declined thereafter, while the p18ppk1 and pduABJKNU 19 expressing strain retained approximately the same level of cell associated polyphosphate 20 at 48 hours as at 20 hours. 21
22
BMC protects endogenous polyphosphate from exogenous polyphosphatases 23
The induction of non-targeted PPK1 from the pDuet vector increased whole cell 1 polyphosphate levels 5-fold in comparison to control cells containing the BMC shell 2 protein operon and the pDuet vector with no enzyme insert (the enzyme-free control, Fig.  3 3). It did not increase the polyphosphate content of co-expressed recombinant 4 microcompartments when compared to the enzyme-free control. However, P18-PPK1, 5 when co-produced with the BMCs, increased polyphosphate levels in the BMC fraction 8-6
fold in comparison to the enzyme-free control, while giving a similar overall 5-fold 7 increase in whole cell polyphosphate to that seen with expression of non-targeted PPK1. 8 9 Co-expression of non-targeted polyphosphatase PPX with non-targeted PPK1 reduced 10 whole cell polyphosphate levels by 50% compared with non-targeted PPK1 expression 11 alone, with little effect on polyphosphate levels in the microcompartment fraction. Co-12 expression of non-targeted PPX and BMC-targeted P18-PPK1 reduced whole cell 13 polyphosphate levels by 22% and BMC-associated polyphosphate by 18% when compared 14 with microcompartment targeted PPK1 alone. BMC-associated polyphosphate was still at 15 least 2.5 times greater than in cells co-expressing non-targeted PPK1 in the presence or 16 absence of non-targeted PPX. Co-expression of BMC targeted P18-PPK1 with PPX 17 targeted to the microcompartment using a different tag (D60) reduced the BMC-associated 18 polyphosphate content by 50% in comparison to the BMC-targeted P18-PPK1 alone, while 19 reducing whole cell polyphosphate by 22%. These data suggest that the BMC-targeting of 20 PPK1 results in the synthesis of polyphosphate that is located primarily within the BMC 21 fraction of the cell and is relatively inaccessible to cytoplasmic co-expressed PPX, but 22 more accessible to BMC-targeted PPX. 23 1
Microscopy 2
Blue-black granules were apparent with Neisser's stain in a proportion of all cells 3 overexpressing P18-PPK1, but not the E. coli BL21 insert-free control or without any 4 targeted enzyme (Fig. 4) . These appearances are consistent with the accumulation of 5 intracellular polyphosphate in E. coli cells with increased PPK1 activity. All cells 6 overexpressing P18-PPK1 showed a heterogeneous granule phenotype, with a proportion 7 of non-toluidine blue staining cells in all fields. 8 9 E. coli expressing the recombinant microcompartment and P18-PPK1 retained the 10 polyphosphate staining at 44 hours (Fig. 4) whereas cells expressing P18-PPK1 without 11 the recombinant microcompartment showed reduced staining after 40 hours (Fig. 3) . 12
All E.coli expressing the recombinant microcompartment had a proportion of cells which 13 were greatly elongated. All E.coli forming multiple polyphosphate granules tended to be 14 larger than the non-granulated cells, presumably because of distension by the granules. 15
However, the largest cells were seen with the combination of recombinant 16 microcompartment and P18-PPK1. 17 18
Electron-loss spectroscopic analysis by Energy-filtered Transmission Electron 19
Microscopy (EFTEM). 20 21
Increased phosphorus deposition was detected in all cells expressing recombinant E.coli 22 PPK1 (Fig. 5C,D,E,F) , verified from PEELS measurement (see below), compared with 23 control E. coli strains with no recombinant gene expression (Fig. 5A) or expressing 1 microcompartment genes (Fig. 5B) . In cells expressing PPK1 alone, most phosphate signal 2 was represented by particles <5 nm, but some large homogeneous masses > 200 nm with 3 plane edges were visible (Fig. 5C ) in a few cells. In cells expressing targeted PPK1 and a 4 recombinant microcompartment operon, in addition to signals from particles <5 nm, 5 multiple phosphate signals from particles 50-100 nm were present (Fig.5D,E,F) and in 6 some cases large circular masses/crescents > 300 nm were present (Fig. 5D,F) . These large 7 masses were not homogeneous and appeared composed of small particles and the cells 8 containing them were enlarged. These images appeared similar to light microscopy 9 observations (Fig. 4D,H,L) . 10 11
Parallel electron energy loss spectroscopy (PEELS) 12
Spot-PEELS recorded from dark inclusions apparent as electron dense regions about 100 13 nm in diameter (Fig 5G) , confirmed they contained phosphate, verified from the 14 characteristic ELNES-fingerprint (Energy-Loss Near-Edge Structure) of reference spectra 15 that were recorded from sodium polyphosphate (Fig.5G) . The largest polyphosphate 16 inclusion in figure 5E , shown in yellow, is magnified in the inset of the spot-PEELS ( Fig.  17   5G) [14, 15] . Because this also occurs in E. coli overexpressing ppk with 16 no chromosomal functioning ppx gene it has been suggested to be due to either product-17 induced reversal of the PPK-catalysed reaction, or the activity of another phosphatase 18 enzyme present in the cytoplasm [15] . We observed a similar reversal of polyphosphate 19 accumulation in our overexpressing ppk clone, accompanied by increasing Pi in the culture 20 supernatant (Fig. 2) . This did not occur when the ppk gene was engineered to encode an N-21
terminal BMC localisation sequence and was expressed in trans with an operon encoding 22
for an empty BMC. 23 1 Cells co-producing P18-PPK1 and the empty BMC had a different phosphorus distribution 2 by EFTEM (Fig 5D,E,F) to those expressing PPK1 alone (Fig. 5C) , containing single or 3 agglomerated particles in the BMC size range. BMC extractions show the presence of 4 metabolically active PPK1 (Fig.1C,D) and polyphosphate in the BMC fraction 5 (Fig.1D,Fig.3 ) when PPK1 is microcompartment-targeted in this way. Our results suggest 6 that targeting of PPK1 to a bacterial microcompartment still allows access of the small 7 molecule substrate ATP to the enzyme ( Figure 1A ), but effectively stabilises the large 8 polymer polyphosphate product (Fig. 2B,3) . 9
10
We hypothesized that this stabilisation results from reduced access of PPX, GPPA or 11 other cytoplasmic phosphatases to the polyphosphate produced by BMC-targeted PPK1. 12
To confirm this we carried out co-expression experiments of PPK1 with PPX (Fig. 3) . 13
Co-production of PPX with PPK1 resulted in lower cellular polyphosphate levels than 14 expression of ppk1 alone (Fig. 3) , as has been previously reported [62] . This reduction in 15 total cellular polyphosphate was partially prevented by BMC-association of PPK1, due to 16 increased levels of polyphosphate in the BMC fraction. BMC-targeting of PPK1 therefore 17 results in the synthesis of polyphosphate that is located primarily in the BMC fraction of 18 the cell. Polyphosphate in the BMC fraction is inaccessible to cytoplasmic co-expressed 19 
18
Our results demonstrate that P18-PPK1 is targeted to a recombinant BMC. The 19 observation that polyphosphate accumulates within the BMC suggests that targeted PPK1 20 is internalised within the structure and remains functional, generating polymeric product. 21 ATP must be able to enter the recombinant BMC to allow it to act as one of the substrates 22 for the P18-PPK1 enzyme (Fig. 1A) . However, this is not surprising as the native Pdu 23 BMC must allow ATP access as it is required by PduO (located within the 1 microcompartment) for the regeneration of the coenzyme form of cobalamin needed by 2 the diol dehydratase complex [69] . The association of PPK1 with the BMC however 3 leads to sequestration of the enzyme's metabolic product, presumably because its size 4 does not allow it to leave the BMC by the same route by which the enzyme substrate 5 ATP arrived. Protection of the polyphosphate product from catabolism from cytosolic 6 enzymes is therefore achieved, illustrating a general mechanism by which BMC can be 7 used to re-engineer cellular metabolism. The specific polymer generated, polyphosphate, 8
is an important intermediary in the enhanced biological phosphate removal (EBPR) 9 process employing environmental bacteria to remove phosphate from wastewater [3, 12] 10 and has industrial applications [70] . EBPR requires prolonged cycles of aerobic and 11 aerobic incubation to operate. The ability to stabilise polyphosphate produced in a single 12 growth phase so that phosphate is not returned to the cell exterior could lead to a 13 streamlined process with a single phase of incubation. DE3 pML01 (pduP18-ppk1) . D,E,F,G: E. coli Tuner TM (DE3) pET23bPduP18ppk1 pLySsPduABJKNU. A-F: Electron spectroscopic imaging. Phosphorus signals are shown as overlays: green in A,B,C Parallel electron energyloss spectroscopy (PEELS) of the largest granule in E. The red line represents SpotPEELS of the large inclusion from E with the spot (size: 16 nm) placed centrally (electron micrograph inset). The green-boxed area represents the P-L2,3 energy-loss near-edge structure (ELNES), characterized by the two peaks (asterisks). The blue-coloured dashed spectrum is referenced from sodium polyphosphate.
